Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download PDFDownload PDF 

Previous Fragment    Next Fragment


Senator Xenophon amended business of the Senate notice of motion no. 2 by leave and, pursuant to notice of motion not objected to as a formal motion, moved—That the following matter be referred to the Community Affairs References Committee for inquiry and report by 12 October 2011:

The regulatory standards for the approval of medical devices in Australia, with particular attention to devices with high revision rates, and in undertaking the inquiry the committee consider:

 (a) the role of the Therapeutic Goods Administration in regulating the quality of devices available in Australia;

 (b) the cost effectiveness of subsidised devices;

 (c) the effectiveness and accuracy of the billing code and prostheses list;

 (d) the processes in place to ensure that approved products continue to meet Australian standards;

 (e) the safety standards and approval processes for devices that are remanufactured for multiple use;

 (f) the processes in place to notify the relevant authorities and the general public of high revision rates or possible faulty devices;

 (g) the effectiveness of the current regimes in place to ensure prostheses with high revision rates are identified and the action taken once these devices are identified;

 (h) the effectiveness of the implemented recommendations of the Health Technology Assessment; and

 (i) any other related matter.

Statement by leave: Senator Xenophon, by leave, made a statement relating to the motion.

Question put and passed.